A current update on osteonecrosis of the jaw and bisphosphonates abstract. There is no test to measure onj risk, but some factors are known to raise this risk in very rare. Bisphosphonates bps have been used for the management of bone metabolic diseases. Medicationrelated osteonecrosis of the jaw mon, mronj is progressive death of the jawbone in a person exposed to a medications known to increase the risk of disease, in the absence of a previous radiation treatment. Further research is needed to increase knowledge about the underlying. Bisphosphonates and osteonecrosis of the jaw bisphosphonate medications are linked to a risk of osteonecrosis of the jaw. Oral bisphosphonates are the most commonly prescribed antiresorptive drugs for the treatment of osteoporosis.
The patients taking bisphosphonates are at increased risk of developing bisphosphonaterelated osteonecrosis of jaw bronj which is characterised by the presence of an unhealing wound after dental surgery. This material may not otherwise be downloaded, copied, printed, stored, transmitted. This report documents a case of bisphosphonaterelated osteonecrosis of the jaw mronj. Bisphosphonate and osteonecrosis of the jaw litwiniuk. Risk of jaw osteonecrosis after intravenous bisphosphonates in cancer patients and patients without cancer. Osteonecrosis of the jaw onj is a wellknown side effect of bisphosphonate bp therapy.
Further research is needed to increase knowledge about the underlying mechanisms and risk factors for onj, and about. Nov 21, 2006 woo and colleagues 1 highlight the substantial difference in the risk for osteonecrosis of the jaw between patients with cancer who receive high doses of intravenous bisphosphonates and patients with nonmalignant skeletal disorders who receive considerably lower doses, but their recommendations for managing the disorder do not reflect the difference. Incidence in a homogeneous series of patients with newly diagnosed. Nov 21, 2006 however, their paper includes serious misstatements about bisphosphonates and bone. Biphosphonatesrelated osteonecrosis of the jaw bialozyk. Onj is specif ically related to the intravenous form of bps and is. In this report, we compare the incidence of jaw osteonecrosis among patients with cancer versus patients without cancer who received iv bisphosphonates. We present a case of a 77yearold woman with metastatic breast cancer and osteonecrosis of the jaw after a longterm intravenous treatment with bisphosphonate.
Bisphosphonate related osteonecrosis of the jaws bronj in. Dec 20, 2012 clinical findings of bisphosphonaterelated osteonecrosis of the jaw bronj bisphosphonaterelated osteonecrosis of the jaw bronj is an area of uncovered bone in the maxillofacial region that did not heal within 8 weeks after identification by health care provider, in a patient who was receiving or had been exposed to bisphosphonate therapy bpt without previous radiation therapy to the. With a better understanding of this side effect, reported incidences for bronj in oral bisphosphonate users have increased in time. To evaluate the level of knowledge of dentists from plovdiv, bulgaria, about possible complications of bisphosphonate therapy of patients in dental practice. The following protocols have been developed by the bc cancer agency department of oral oncology. Nih funding opportunities and notices in the nih guide for grants and contracts. Osteonecrosis of the jaw is a rare complication that has been associated with the use of bisphosphonates.
May 16, 20 oral bisphosphonates are the most commonly prescribed antiresorptive drugs for the treatment of osteoporosis. Bisphosphonates are used to treat osteoporosis, osteitis deformans pagets disease of the bone, bone metastasis with or without hypercalcaemia, multiple myeloma, and other conditions involving fragile, breakable bone. Abstractthe literature describes an increasing presence of bisphosphonateinduced. The american college of prosthodontists agrees with the recommendation for the term, medicationrelated osteonecrosis of the jaw mronj suggested by the american association of maxillofacial surgeons aaoms to replace the previous, morespecific term, bisphosphonate related. Bisphosphonate medications bisphosphonates are a class of medications which include pamidronate aredia. This article aims to provide an overview of bisphosphonates and bronj, to improve the awareness among. Oral bisphosphonates spontaneous osteonecrosis of the jaw. Bisphosphonates and osteonecrosis of the jaw bonefos clodronate and didronel etidronate, both irstgeneration bisphosphonates do not have an amino group moiety nitrogencontaining on the r2 long sidechain. It is recommended that you have a good dental exam prior to starting these medications. Citing the beagle dog study by mashiba and colleagues 2, woo and colleagues state that prolonged use of bisphosphonates may suppress bone turnover to the point that microdamage persists and accumulates, resulting in decreased biomechanical competence.
Medicationrelated osteonecrosis of the jaw wikipedia. Pdf bisphosphonateinduced osteonecrosis of the jaws. Bisphosphonates have been increasingly recommended for use in patients with osteoporosis, pagets disease, hypercalcemia of malignancy, osteolytic bone metastases, and osteolytic lesions of multiple myeloma. Bone metastases occur in about 80% of men with advanced prostate cancer, 1 75% of patients with metastatic breast cancer 2 and 30% to 60% of patients with advanced metastatic lung cancer, 3 and are present in 35% of. Radicalsurgicaltreatmentofbisphosphonaterelatedosteonecrosisofthejaw. Pdf bisphosphonateinduced osteonecrosis of the jaw. Just as an extraction requires bone turnover to heal, dental implants require bone turnover to maintain osseointegration. The relationship between osteonecrosis of the jaw and bisphosphonate therapy has been described recently.
Osteonecrosis of the jaw is typically associated with trauma to the jaw tooth extraction, history of malignancy andor infections while on bisphosphonate therapy. The incidence of bone metastases is high among patients with advanced cancer. Pdf bisphosphonate related osteonecrosis of the jaw. Bisphosphonates and osteonecrosis of the jaw bc cancer. The earliest report of bisphosphonate associated jaw osteonecrosis occurred after 4 months of treatment. As a result, they are widely used for the prevention and treatment of osteoporosis. Osteonecrosis of the jaw onj is a very rare side effect of bisphosphonates. These benefits outweigh the risk of side effects of bisphosphonates, which are minimal.
Bisphosphonates for osteopenia in postmenopausal women jama. John bilezikian asks whether there is a relationship between bisphosphonates and osteonecrosis of th. Antiresorptiverelated osteonecrosis of the jaw aronj is a rare but severe side effect of antiresorptive treatment with bisphosphonates or ranklantibody denosumab in patients with malignant diseases or osteoporosis. Bisphosphonateinduced osteonecrosis of the jaw request pdf. However, there have been no headtohead dose comparisons of jaw osteonecrosis after iv bisphosphonates for cancer vs noncancer indications. Cumulative incidence of bisphosphonate associated osteonecrosis of the jaw in the oncology patient population. Several recent reports have described osteonecrosis of the jaws onj associated with the use of bisphosphonates. Selfhealing lesion of bisphosphonate induced osteonecrosis of.
Bisphosphonate complications including osteonecrosis of. To examine the incidence rates and association between doseintensity, stratified by exposure duration, of bisphosphonates and the risk of osteonecrosis of the jaw among korean osteoporotic patients older than 50 years. Endodontic implications of bisphosphonateassociated osteonecrosis of the jaws aae position statement. Bisphosphonates inhibit bone resorption with relatively few side effects. However, there are several adverse effects associated with oral bisphosphonates including the bisphosphonate related osteonecrosis of the jaw bronj.
In osteoporosis and pagets, the most popular firstline bisphosphonate drugs are alendronate and risedronate. Risk factors for bisphosphonate associated jaw osteonecrosis. Periodontal disease, dentoalveolar surgery, prior trauma, corticosteroid therapy, immunecompromised state predisposing to increased risk of infection, possible vascular insufficiency and an underlying hypercoagulable state secondary to underlying malignancy have been. However, you should be aware of this rare but potentially. Although bisphosphonates have a long list of benefits in the treatment of patients with bone metastases, an increasing number of reports describe the complication of bisphosphonaterelated osteonecrosis of the jaw bronj. There is little doubt that iv bisphosphonates can cause osteonecrosis of the jaw. With a better understanding of this side effect, reported incidences for bronj in oral bisphosphonate users have. Jun 04, 2006 the risk of jaw osteonecrosis increased with duration of exposure to intravenous bisphosphonate, with the median time of exposure until the development of jaw osteonecrosis of 22 to 39 months. Guidelines for bisphosphonateassociated osteonecrosis of the jaw khan aa, sandor gk, dore e, et al. Bisphosphonaterelated osteonecrosis of the jaw in patients with. Bisphosphonates are synthetic analogues of pyrophosphate that.
Background the purpose of this study was to describe the clinical characteristics. Rheumatologists treating bone diseases with bisphosphonate need, therefore, to be aware of this potential risk and plan the prophylaxis, early diagnosis and prevention of. Bisphosphonate associated osteonecrosis of the jaw. It has been speculated that the medication, especially longterm i. A medline search 1966january 2007 and a search of international pharmaceutical abstracts 1970january 2007 were. Pathophysiology of bisphosphonatesassociated osteonecrosis of the jaw r21 pa06501. Bisphosphonates are a group of drugs used in the treatment of many common diseases, such osteoporosis, bone metastasis, myeloma. Severe case of osteonecrosis following implant placement in a. Iv forms of bisphosphonates are used with some cancer treatments and it raises the risks of developing medication related osteonecrosis of the jaw mronj. Oral use of bisphosphonates for osteonecrosis of the hip has shown some early.
Read download file report abuse imaging of bisphosphonate related osteonecrosis of the jaw aaoms position paper on bisphosphonaterelated osteonecrosis of the jaw 2009 update approved by the board of trustees january 2009 task force on. Pamidronate aredia and zoledronate zometa induced avascular necrosis of the jaws. Bisphosphonates and osteonecrosis of the jaw annals of. Bisphosphonateassociated osteonecrosis of the jaws. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Bisphosphonate drug holidays can be considered for patients who have persisted with bisphosphonate therapy for 3 to 5 years and for those at low risk of fracture. Clinical findings of bisphosphonaterelated osteonecrosis of the jaw bronj bisphosphonaterelated osteonecrosis of the jaw bronj is an area of uncovered bone in the maxillofacial region that did not heal within 8 weeks after identification by health care provider, in a patient who was receiving or had been exposed to bisphosphonate therapy bpt without previous radiation. Osteonecrosis of the jaws is uncommon in patients who have taken oral bisphosphonates for less than three years. Bisphosphonaterelated osteonecrosis of the jaw a 3years.
Pdf bisphosphonate associated osteonecrosis of the jaw. Osteonecrosis of the jaw in patients treated with bisphosphonates is a relatively rare but well known complication at maxillofacial units around the world. Bisphosphonate complications including osteonecrosis of the. The mechanism of bisphosphonatesinduced osteonecrosis is unclear.
Rheumatologists treating bone diseases with bisphosphonate need, therefore, to be aware of this potential risk and plan the prophylaxis, early diagnosis and prevention of potential consequences. Frontiers doseintensity of bisphosphonates and the risk. Oral bisphosphonate related osteonecrosis of the jaw. Using the populationbased national health insurance claims data of korea from january 1, 2006, through december 3, 2012. Frontiers doseintensity of bisphosphonates and the risk of. Guidelines for bisphosphonateassociated osteonecrosis of the.
This article is from journal of clinical and experimental dentistry, volume 4. Invasive procedure such as tooth extraction and bone biopsies should be avoided. Osteonecrosis of the jaw is a potential complication of nitrogencontaining bisphosphonates. Since 2003 an increasing number of bisphosphonaterelated osteonecrosis of the jaw bronj were reported. Jan 01, 2006 the mechanism of bisphosphonates induced osteonecrosis is unclear. She reported that in may 2009, she underwent an implant rehabilitation with 8 implants and an immediately loaded fixed prosthesis in the maxilla. Bisphosphonates are recommended in the treatment of osteoporosis and some cancers, in which case they prevent the appearance of bone metastasis. Reports of this complication have increased recently. Their role is to inhibit osteoclast function, leading to lower bone resorption. However, their paper includes serious misstatements about bisphosphonates and bone. Risk of osteonecrosis of the jaw in cancer patients taking. The condition is called bisphosphonate related osteonecrosis of the jaw bronj 16, which was changed by the. Effects of bisphosphonates tend to last even after the person stops taking the medicine.
Guidelines for bisphosphonateassociated osteonecrosis of. Osteonecrosis of the jaw and the role of bisphosphonates. A doubleblind, randomized, placebocontrolled trial of nearly 2000 older women. Using the populationbased national health insurance claims data of korea from january 1, 2006, through december 3, 2012,730 new. Bisphosphonateassociated adverse events springerlink.
Bisphosphonates and osteonecrosis of the jaw side effect. Woo and colleagues 1 highlight the substantial difference in the risk for osteonecrosis of the jaw between patients with cancer who receive high doses of intravenous bisphosphonates and patients with nonmalignant skeletal disorders who receive considerably lower doses, but their recommendations for managing the disorder do not reflect the difference. Bisphosphonaterelated osteonecrosis of the jaw in patients with osteoporosis. Apr 30, 2018 antiresorptiverelated osteonecrosis of the jaw aronj is a rare but severe side effect of antiresorptive treatment with bisphosphonates or ranklantibody denosumab in patients with malignant diseases or osteoporosis. Whilst osteonecrosis of the jaw onj related to the administration of bisphosphonates bps has been investigated for more than 1 decade now, only few data are available. Care guidelines are based on expert opinion but clinical decisions are left up to practitioners. The frequency of osteonecrosis of the jaws associated with dental implants is unknown. Currently their therapeutic use has increased, as also have their adverse effects, one of the most important being the bisphosphonaterelated osteonecrosis of the jaw bronj, a. An overview of other treatment options for osteoporosis in women and men is discussed separately. To the editor the jama insights article on bisphosphonates for postmenopausal osteoporosis commented that no clinical trials have assessed benefit of treatment with bisphosphonates in women with osteopenia. This needs to be considered when developing a dental treatment plan and makes preventive dental care very important. Understanding bisphosphonates and osteonecrosis of the jaw. Osteonecrosis of the jaw do bisphosphonates pose a risk.
Osteonecrosis of the jaw and atypical subtrochanteric and diaphyseal femur fractures might be related to the use of bisphosphonates in osteoporosis, but they are. Periodontal disease, dentoalveolar surgery, prior trauma, corticosteroid therapy, immunecompromised state predisposing to increased risk of infection, possible vascular insufficiency and an underlying hypercoagulable state secondary to underlying malignancy. However, bisphosphonates are under scrutiny because of the risk of bisphosphonaterelated osteonecrosis of the jaw. Mri evaluation of bisphosphonaterelated osteonecrosis of. Whilst osteonecrosis of the jaw onj related to the administration of bisphosphonates bps has been investigated for more than 1 decade now, only few data are available on. Their potential to treat other diseases characterized by osteoclastmediated bone resorption has gained attention. However, several predisposing factors have been identified. Borromeo department of dentistry, university of melbourne, australia. Condition bisphosphonates, like alendronate fosamax, description care management tips osteonecrosis of the jaw onj is a condition where the jawbone is exposed and not covered by gums. It is recommended that patients should have a dental examination prior to treatment with bisphosphonates. Osteonecrosis of the jaw associated with bisphosphonates.
Severe case of osteonecrosis following implant placement. A 77yearold patient presented in april 20 asking for a consultation. Bisphosphonates are effective drugs used to treat important medical conditions affecting the skeleton, such as malignancy and osteoporosis. Page 1 medicationrelated osteonecrosis of the jaw 2014 update. The frequency of osteonecrosis of the jaws associated with dental implants is. Bisphosphonates can also reduce symptoms that pagets disease can cause, such as bone pain, ringing in the ears, dizziness, and numbness or weakness. I am simply informing my chiropractic colleagues of one side affect of a very commonly used treatment for osteoporosis. It may lead to surgical complication in the form of impaired wound healing following oral and maxillofacial surgery, periodontal surgery, or endodontic therapy. Pentoxifylline and tocopherol in the treatment of yearly zoledronic. Oral bisphosphonates alendronate, risedronate and ibandronate, mainly used for the treatment of osteoporosis, have been associated with adverse events from the upper gastrointestinal tract, acute phase response, hypocalcaemia and secondary hyperparathyroidism, musculoskeletal pain. A current update on osteonecrosis of the jaw and bisphosphonates.
Risk of jaw osteonecrosis after intravenous bisphosphonates. Bisphosphonaterelated osteonecrosis of the jaws bronj core. Oct 09, 2006 several recent reports have described osteonecrosis of the jaws onj associated with the use of bisphosphonates. Bisphosphonates for treatment of osteoporosis expected beneits, potential harms, and drug holidays. The most important factor is the time of exposure to bisphosphonates. Guidelines for bisphosphonateassociated osteonecrosis of the jaw. Bisphosphonates and osteonecrosis of the jaws australian. Osteonecrosis of the jaw in patients transitioning from.
It is the r2 sidechain that imparts the potency and method of affect on bone cells. Bisphosphonates may take several months to become fully effective. Bisphosphonateassociated osteonecrosis of the jaws baonj is a side effect of treatment with bisphosphonate bp. Bisphosphonate dental care protocol bisphosphonates and osteonecrosis of the jaw. Most of the people who have gotten onj while taking bisphosphonates have. Sep 01, 2009 bisphosphonates have been increasingly recommended for use in patients with osteoporosis, pagets disease, hypercalcemia of malignancy, osteolytic bone metastases, and osteolytic lesions of multiple myeloma. Oral bisphosphonates as a cause of bisphosphonaterelated bisphosphonaterelated osteonecrosis of the jaws bronj in my patient on oral bisphosphonates. However, the risk of onj for osteoporosis patients taking these types of drugs is very low much lower than the risk of breaking a bone. Bisphosphonateassociated osteonecrosis of the jaw bonj is a rare but painful condition that can affect quality of life. Bisphosphonates and osteonecrosis of the jaw request pdf. If the inline pdf is not rendering correctly, you can download the pdf file here. Bp induced osteonecrosis of maxilla in a patient who was on a low dose oral bp for osteoporosis and the lesion healed. Onj and the medication in question is a family of drugs known as bisphosphonates.
The aim of this study is to describe the radiological features of bisphosphonate osteonecrosis bon in order to aid its prompt recognition. Dental care protocols bisphosphonate medications are linked to a risk of osteonecrosis of the jaw. Bisphosphonates are the most clinically important class of antiresorptive agents available. I am not suggesting patients stop taking bisphosphonates.
1017 159 398 741 166 610 1059 400 496 745 1536 225 963 572 953 693 554 470 631 159 1487 423 1319 1272 793 1554 311 957 401 80 1487 31 1457 343 28 127 797 56 206 162 989 605 1404